16 May Lakewood-Amedex Announces Results Demonstrating The More Rapid Direct Bactericidal Activity Of Novel Bisphosphocin Class Of Antimicrobials
SARASOTA, Fla., May 16, 2013 /PRNewswire/ -- Lakewood-Amedex Inc., a leading developer of novel anti-infective pharmaceuticals, announced today that a recent series of in vitro studies have provided new evidence that its novel class of antimicrobials, named bisphosphocins, function through a completely unique mechanism of...